Panacea Biotec Share Price | Panacea Biotec Stock Screener
PANACEABIO
Pharmaceuticals
Share Price NSE
₹551.20
▲
2.95 (0.54%)
Share Price BSE
₹549.60
▲
2.25 (0.41%)
As of July 3, 2026, the Panacea Biotec share price (NSE: PANACEABIO) is ₹551.20 on NSE and ₹549.60 on BSE, up 0.54% from the previous close, with shares trading between ₹536.00 and ₹556.15, and a 52-week range of ₹296.05–₹607.75.
Analyse PANACEABIO share price charts and track historical price performance.
Use the Panacea Biotec stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Panacea Biotec Market Cap
₹3,391.76 Cr.
PANACEABIO P/E Ratio (TTM)
-478.72
Panacea Biotec P/B Ratio
4.11
EPS (TTM)
₹-0.88
Dividend Yield
-
Debt to Equity
0.02
PANACEABIO 52 Week High
₹607.75
Panacea Biotec 52 Week Low
₹296.05
Operating Margin
2.00%
Profit Margin
-0.58%
PANACEABIO Revenue (TTM)
₹172.00
EBITDA
₹8.00
Net Income
₹-1.00
Total Assets
₹1,262.00
Total Equity
₹835.00
Panacea Biotec Share Price Chart
Screen Panacea Biotec share price with an interactive chart. Analyse PANACEABIO price trends and volatility across different timeframes.
Panacea Biotec Company Profile - Fundamental Screener
Screen Panacea Biotec company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PANACEABIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE922B01023
Panacea Biotec Balance Sheet Screener
Screen PANACEABIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,262 | 1,290 | 1,241 | 1,271 | 1,759 | 1,178 | 1,390 | 1,376 | 1,608 | 1,800 |
| Current Assets | 513 | 545 | 485 | 562 | 951 | 511 | 683 | 508 | 560 | 533 |
| Fixed Assets | 720 | 567 | 582 | 600 | 622 | 609 | 657 | 806 | 949 | 1,001 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 85 | 92 | 94 | 101 | 109 | 960 | 739 | 90 | 611 | 846 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 835 | 831 | 838 | 840 | 874 | -232 | 196 | 347 | 306 | 366 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 829 | 807 | 814 | 816 | 849 | -257 | 139 | 335 | 293 | 340 |
Panacea Biotec Income Statement Screener - Profit & Revenue Analysis
Screen Panacea Biotec income statement and profit fundamentals.
Analyze PANACEABIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Panacea Biotec share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 172 | 169 | 184 | 150 | 170 | 150 | 122 | 155 | 170 | 163 | 163 | 149 | 159 | 1,821 | 151 |
| Expenses | 164 | 159 | 168 | 159 | 153 | 143 | 130 | 140 | 156 | 135 | 140 | 147 | 151 | 171 | 191 |
| EBITDA | 8 | 9 | 16 | -9 | 17 | 8 | -8 | 14 | 14 | 29 | 24 | 2 | 8 | 1,650 | -40 |
| Operating Profit % | 2.00% | -20.00% | -1.00% | -13.00% | 7.00% | -4.00% | -12.00% | 5.00% | 5.00% | -4.00% | -8.00% | -2.00% | 0.00% | -21.00% | -72.00% |
| Depreciation | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 10 | 10 | 9 | 9 | 11 | 10 |
| Interest | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 31 | 1 |
| Profit Before Tax | -1 | 0 | 7 | -19 | 7 | -2 | -17 | 5 | 4 | 18 | 13 | -8 | -2 | 1,608 | -51 |
| Tax | 0 | 2 | 3 | -5 | 3 | 0 | -1 | 0 | 0 | 31 | 2 | 1 | 1 | 371 | 5 |
| Net Profit | -1 | -2 | 4 | -14 | 4 | -2 | -16 | 5 | 4 | -13 | 11 | -8 | -2 | 1,238 | -56 |
| EPS | 0.08 | -0.31 | 0.66 | -2.27 | 0.65 | -0.23 | -2.59 | 0.77 | 0.74 | -2.03 | 1.79 | -1.35 | -0.37 | 202.03 | -9.17 |
Panacea Biotec Cash Flow Screener - Liquidity Fundamentals
Screen PANACEABIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -27 | 0 | -423 | -108 | 107 | -31 | 105 | 118 | 131 | 91 |
| Investing Activities | 65 | 10 | 430 | 1,283 | -48 | -35 | -6 | 55 | -26 | 17 |
| Financing Activities | -3 | -3 | -18 | -1,176 | -47 | 91 | -101 | -164 | -107 | -117 |
| Net Cash Flow | 35 | 7 | -11 | -2 | 12 | 26 | -2 | 9 | -2 | -10 |
Panacea Biotec Shareholding Pattern Screener
See Panacea Biotec shareholding pattern with promoter, FII, and DII holdings.
Check Panacea Biotec promoter holding and ownership changes for PANACEABIO on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | 73.59% | 73.46% | 72.87% |
| FII Holding | 1.60% | 1.16% | 0.78% | 1.06% | 1.36% | 0.27% | 0.27% | 0.37% |
| DII Holding | 1.97% | 1.49% | 1.52% | 1.81% | 1.85% | 0.84% | 1.07% | 1.16% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.81% | 18.45% | 18.17% | 17.69% | 17.49% | 19.90% | 20.42% | 18.11% |
| Other Holding | 7.15% | 6.41% | 7.05% | 6.96% | 6.81% | 5.40% | 4.79% | 7.49% |
| Shareholder Count | 32,620 | 33,593 | 34,256 | 33,593 | 34,597 | 46,242 | 45,513 | 39,982 |
Panacea Biotec Share Dividend Screener - Share Yield Analysis
Check Panacea Biotec dividend history with payout and yield data.
View Panacea Biotec dividend details including ex-dates and amounts for PANACEABIO stock.
Panacea Biotec Stock Index Membership
See which indices include Panacea Biotec stock.
Check PANACEABIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Panacea Biotec Market Events Screener - Corporate Actions
Get Panacea Biotec corporate actions including splits, bonuses, and buybacks.
Check Panacea Biotec stock events that may affect PANACEABIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.67% | ||
| Annual General Meeting | NA | -17.99% | ||
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | -1.53% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 2.36% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -6.47% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 7.49% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.52% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 5.62% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 12.32% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 0.00% |
Panacea Biotec Competitors Screener - Peer Comparison
Screen PANACEABIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,827 | 38.82 | 58,220 | 6.38% | 11,565 | 65.03 |
| Divis Laboratories | 174,081 | 69.38 | 10,560 | 8.73% | 2,520 | 43.32 |
| Torrent Pharmaceuticals | 157,634 | 71.51 | 13,886 | 20.34% | 2,138 | 66.05 |
| Cipla | 117,459 | 30.13 | 29,045 | 2.24% | 3,870 | 68.02 |
| Dr Reddys Laboratories | 114,822 | 27.10 | 33,593 | -0.44% | 3,998 | 73.77 |
| Zydus Life Science | 112,829 | 21.63 | 26,720 | 13.65% | 5,242 | 66.06 |
| Lupin | 110,115 | 20.00 | 27,488 | 19.98% | 5,345 | 66.98 |
| Mankind Pharma | 102,623 | 52.44 | 14,278 | 12.03% | 1,750 | 59.48 |
| Aurobindo Pharma | 89,879 | 25.78 | 33,385 | 3.21% | 3,376 | 65.10 |
| Laurus Labs | 80,995 | 88.02 | 6,868 | 22.01% | 890 | 70.64 |
Panacea Biotec Company Announcements - News Screener
Screen PANACEABIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Closure of Trading Window | - |
| 2026-06-17 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-06-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-05 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-05 | Details Of Shares Dematerialized During May 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018 | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-31 | Audited Financial Results For Quarter And Financial Year Ended March 31 2026 | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-05-30 | Board Meeting Outcome for 1. Standalone And Consolidated Audited Financial Results For The Quarter And Financial Year Ended 31.03.2026 2. Passing Over Of Dividend For The Financial Year 2025-26 3. Appointment Of Mr. Rajinder Singh Manku As Non-Executive | - |
| 2026-05-29 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Read With Para A Of Part A Of Schedule III Of The Said Regulations | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-26 | Update on board meeting | - |
| 2026-05-23 | Board Meeting Intimation for Inter-Alia Approving Standalone And Consolidated Audited Financial Results For Quarter And Financial Year Ended March 31 2026 | - |
| 2026-05-07 | Details Of Shares Dematerialized During April 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018 | - |
| 2026-04-30 | Intimation Of Fire Incident At Oncology Facility Of The CompanyS Wholly Owned Subsidiary Panacea Biotec Pharma Limited At Baddi Himachal Pradesh | - |
| 2026-04-30 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-04-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-11 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2026-04-10 | Receipt Of Awards From The Presiding Officer Of Industrial Tribunal Mohali | - |